Marco Busutti

605 total citations
28 papers, 291 citations indexed

About

Marco Busutti is a scholar working on Public Health, Environmental and Occupational Health, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marco Busutti has authored 28 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Nephrology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Busutti's work include Renal Transplantation Outcomes and Treatments (7 papers), Renal and related cancers (5 papers) and Organ Donation and Transplantation (4 papers). Marco Busutti is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Renal and related cancers (5 papers) and Organ Donation and Transplantation (4 papers). Marco Busutti collaborates with scholars based in Italy, United Kingdom and Spain. Marco Busutti's co-authors include Franco Arturi, Maria Chiara Pelle, Michele Provenzano, Riccardo Magistroni, Gaetano La Manna, Francesca Testa, Giulia Ligabue, Andrea Solazzo, Giacomo Mori and Silvia Giovanella and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Marco Busutti

26 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Busutti Italy 8 76 68 56 38 36 28 291
Ashraf El‐Meanawy United States 12 125 1.6× 32 0.5× 138 2.5× 43 1.1× 31 0.9× 25 395
Kazuo Komatsu Japan 10 95 1.3× 17 0.3× 75 1.3× 82 2.2× 20 0.6× 23 340
Humaira Rasheed Norway 11 62 0.8× 68 1.0× 123 2.2× 60 1.6× 24 0.7× 18 305
Marina Sapojnikov Israel 8 80 1.1× 78 1.1× 79 1.4× 67 1.8× 42 1.2× 12 340
José Guilherme Ferreira Marques Galvão Brazil 7 97 1.3× 22 0.3× 139 2.5× 30 0.8× 26 0.7× 26 403
Øystein Aagenæs Norway 13 74 1.0× 107 1.6× 45 0.8× 127 3.3× 24 0.7× 23 417
Nóra Fanni Bánki Hungary 8 113 1.5× 30 0.4× 29 0.5× 56 1.5× 26 0.7× 11 286
Thutrang Nguyen United States 7 63 0.8× 114 1.7× 23 0.4× 33 0.9× 50 1.4× 9 375
Peihao Liu China 13 98 1.3× 39 0.6× 7 0.1× 53 1.4× 99 2.8× 30 481
Costas Haitoglou Greece 11 95 1.3× 18 0.3× 27 0.5× 14 0.4× 14 0.4× 24 360

Countries citing papers authored by Marco Busutti

Since Specialization
Citations

This map shows the geographic impact of Marco Busutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Busutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Busutti more than expected).

Fields of papers citing papers by Marco Busutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Busutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Busutti. The network helps show where Marco Busutti may publish in the future.

Co-authorship network of co-authors of Marco Busutti

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Busutti. A scholar is included among the top collaborators of Marco Busutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Busutti. Marco Busutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noble, Johan, Giorgia Comai, Céline Dard, et al.. (2025). Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study. Transplant International. 38. 14502–14502.
2.
Busutti, Marco, et al.. (2024). Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement. International Journal of Molecular Sciences. 25(5). 2554–2554. 3 indexed citations
3.
Maritati, Federica, Valeria Corradetti, Claudia Bini, et al.. (2024). “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy. Kidney International Reports. 9(4). 982–993. 7 indexed citations
4.
Busutti, Marco, Olga Baraldi, Claudia Bini, et al.. (2023). Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease. Kidney International Reports. 8(8). 1676–1679.
5.
Busutti, Marco, Andrea Vacirca, Chiara Donadei, et al.. (2023). Renal Benefits of CO2 as a Contrast Media for EVAR Procedures: New Perspectives on 1 Year Outcomes. Journal of Endovascular Therapy. 31(6). 1180–1189. 3 indexed citations
6.
Fallani, Guido, Lorenzo Maroni, Giorgia Comai, et al.. (2023). Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant. Transplant International. 36. 11060–11060. 2 indexed citations
7.
Santoro, Francesco, Simona Simone, Carlo Alfieri, et al.. (2023). Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists. European Journal of Internal Medicine. 119. 71–77. 6 indexed citations
8.
Vivarelli, Marina, Manuela Colucci, Mattia Algeri, et al.. (2023). A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome. JCI Insight. 8(18). 9 indexed citations
9.
Fais, Giacomo, Federico Bolognesi, Massimiliano Borselli, et al.. (2022). Wide Range Applications of Spirulina: From Earth to Space Missions. Marine Drugs. 20(5). 299–299. 48 indexed citations
10.
Pelle, Maria Chiara, et al.. (2022). Up-Date on Diabetic Nephropathy. Life. 12(8). 1202–1202. 67 indexed citations
11.
Maritati, Federica, Claudia Bini, Vania Cuna, et al.. (2022). Current Perspectives in ABO-Incompatible Kidney Transplant. Journal of Inflammation Research. Volume 15. 3095–3103. 5 indexed citations
12.
Maritati, Federica, Michele Provenzano, Valeria Corradetti, et al.. (2022). Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome. Frontiers in Immunology. 13. 878736–878736. 4 indexed citations
13.
Pasini, Andrea, Claudio La Scola, Francesca Mencarelli, et al.. (2022). The process of transition from pediatric to adult healthcare services for nephrological patients: Recommendations vs. reality—A single center experience. Frontiers in Pediatrics. 10. 954641–954641. 3 indexed citations
15.
Giglio, Andrea De, Marco Busutti, Gisella Vischini, et al.. (2022). Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience. Lung Cancer. 174. 91–96. 9 indexed citations
16.
Pasini, Andrea, Claudio La Scola, Francesca Mencarelli, et al.. (2021). Multidisciplinarity in Transition Pathways for Patients With Kidney Disease: The Current State of Play. Frontiers in Pediatrics. 9. 689758–689758. 8 indexed citations
17.
Busutti, Marco, Francesca Diomedi‐Camassei, Roberta Donadelli, et al.. (2020). Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome. Kidney International Reports. 6(2). 534–537. 10 indexed citations
19.
Montini, Giovanni, et al.. (2017). A questionnaire survey of radiological diagnosis and management of renal dysplasia in children. Journal of Nephrology. 31(1). 95–102. 6 indexed citations
20.
Busutti, Marco, et al.. (2017). Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment. American Journal of Nephrology. 45(5). 373–379. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026